Annual Total Long Term Liabilities
$89.42 B
+$30.27 B+51.17%
31 December 2023
Summary:
Pfizer annual total long term liabilities is currently $89.42 billion, with the most recent change of +$30.27 billion (+51.17%) on 31 December 2023. During the last 3 years, it has risen by +$24.58 billion (+37.92%). PFE annual total long term liabilities is now at all-time high.PFE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$83.71 B
-$692.00 M-0.82%
30 September 2024
Summary:
Pfizer quarterly total long term liabilities is currently $83.71 billion, with the most recent change of -$692.00 million (-0.82%) on 30 September 2024. Over the past year, it has dropped by -$2.97 billion (-3.43%). PFE quarterly long term liabilities is now -6.39% below its all-time high of $89.42 billion, reached on 31 December 2023.PFE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.2% | -3.4% |
| 3 y3 years | +37.9% | +36.3% |
| 5 y5 years | +40.1% | +23.0% |
PFE Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +51.2% | -6.4% | +44.8% |
| 5 y | 5 years | at high | +51.2% | -6.4% | +44.8% |
| alltime | all time | at high | >+9999.0% | -6.4% | >+9999.0% |
Pfizer Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $83.71 B(-0.8%) |
| June 2024 | - | $84.40 B(-4.1%) |
| Mar 2024 | - | $88.04 B(-1.5%) |
| Dec 2023 | $89.42 B(+51.2%) | $89.42 B(+3.2%) |
| Sept 2023 | - | $86.68 B(+0.5%) |
| June 2023 | - | $86.23 B(+49.1%) |
| Mar 2023 | - | $57.82 B(-2.3%) |
| Dec 2022 | $59.15 B(-3.6%) | $59.15 B(+1.7%) |
| Sept 2022 | - | $58.15 B(-3.8%) |
| June 2022 | - | $60.41 B(-2.4%) |
| Mar 2022 | - | $61.89 B(+0.9%) |
| Dec 2021 | $61.34 B(-5.4%) | $61.34 B(-0.1%) |
| Sept 2021 | - | $61.42 B(-3.9%) |
| June 2021 | - | $63.94 B(+1.0%) |
| Mar 2021 | - | $63.30 B(-2.4%) |
| Dec 2020 | $64.84 B(-3.0%) | $64.84 B(-18.3%) |
| Sept 2020 | - | $79.33 B(-1.6%) |
| June 2020 | - | $80.65 B(+20.2%) |
| Mar 2020 | - | $67.11 B(+0.4%) |
| Dec 2019 | $66.84 B(+4.8%) | $66.84 B(-1.8%) |
| Sept 2019 | - | $68.08 B(+6.0%) |
| June 2019 | - | $64.25 B(-3.9%) |
| Mar 2019 | - | $66.84 B(+4.8%) |
| Dec 2018 | $63.81 B(-8.5%) | $63.81 B(-5.0%) |
| Sept 2018 | - | $67.16 B(+7.1%) |
| June 2018 | - | $62.70 B(-6.0%) |
| Mar 2018 | - | $66.71 B(-4.3%) |
| Dec 2017 | $69.71 B(-13.6%) | $69.71 B(-15.8%) |
| Sept 2017 | - | $82.82 B(+0.2%) |
| June 2017 | - | $82.68 B(-2.9%) |
| Mar 2017 | - | $85.17 B(+5.6%) |
| Dec 2016 | $80.66 B(+10.5%) | $80.66 B(+0.7%) |
| Sept 2016 | - | $80.07 B(+6.1%) |
| June 2016 | - | $75.49 B(+6.6%) |
| Mar 2016 | - | $70.85 B(-2.9%) |
| Dec 2015 | $72.98 B(-1.8%) | $72.98 B(-3.8%) |
| Sept 2015 | - | $75.90 B(+9.1%) |
| June 2015 | - | $69.56 B(-4.5%) |
| Mar 2015 | - | $72.83 B(-2.1%) |
| Dec 2014 | $74.36 B(+3.1%) | $74.36 B(+1.7%) |
| Sept 2014 | - | $73.14 B(-0.8%) |
| June 2014 | - | $73.72 B(+6.9%) |
| Mar 2014 | - | $68.95 B(-4.4%) |
| Dec 2013 | $72.11 B(-3.8%) | $72.11 B(-6.1%) |
| Sept 2013 | - | $76.79 B(-0.1%) |
| June 2013 | - | $76.91 B(-0.2%) |
| Mar 2013 | - | $77.03 B(+2.8%) |
| Dec 2012 | $74.93 B(-2.0%) | $74.93 B(+5.0%) |
| Sept 2012 | - | $71.36 B(-1.0%) |
| June 2012 | - | $72.08 B(-3.8%) |
| Mar 2012 | - | $74.91 B(-2.0%) |
| Dec 2011 | $76.47 B(-2.1%) | $76.47 B(-1.6%) |
| Sept 2011 | - | $77.75 B(+1.7%) |
| June 2011 | - | $76.47 B(+1.6%) |
| Mar 2011 | - | $75.25 B(-3.7%) |
| Dec 2010 | $78.14 B(-8.4%) | $78.14 B(-1.3%) |
| Sept 2010 | - | $79.17 B(-0.4%) |
| June 2010 | - | $79.51 B(+0.5%) |
| Mar 2010 | - | $79.11 B(-7.2%) |
| Dec 2009 | $85.28 B(+223.0%) | $85.28 B(+67.0%) |
| Sept 2009 | - | $51.05 B(+2.1%) |
| June 2009 | - | $49.99 B(+27.7%) |
| Mar 2009 | - | $39.15 B(+48.3%) |
| Dec 2008 | $26.40 B(-6.7%) | $26.40 B(+0.5%) |
| Sept 2008 | - | $26.25 B(-1.3%) |
| June 2008 | - | $26.60 B(-9.2%) |
| Mar 2008 | - | $29.31 B(+3.5%) |
| Dec 2007 | $28.31 B(+28.6%) | $28.31 B(+0.8%) |
| Sept 2007 | - | $28.09 B(+3.4%) |
| June 2007 | - | $27.17 B(+10.0%) |
| Mar 2007 | - | $24.69 B(+12.2%) |
| Dec 2006 | $22.02 B | $22.02 B(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $21.18 B(-7.9%) |
| June 2006 | - | $23.01 B(-2.8%) |
| Mar 2006 | - | $23.68 B(+3.9%) |
| Dec 2005 | $22.79 B(-19.6%) | $22.79 B(-1.5%) |
| Sept 2005 | - | $23.14 B(-5.3%) |
| June 2005 | - | $24.43 B(-7.6%) |
| Mar 2005 | - | $26.45 B(-6.7%) |
| Dec 2004 | $28.34 B(+3.1%) | $28.34 B(-0.9%) |
| Sept 2004 | - | $28.61 B(+1.8%) |
| June 2004 | - | $28.10 B(-1.8%) |
| Mar 2004 | - | $28.60 B(+4.1%) |
| Dec 2003 | $27.49 B(+250.1%) | $27.49 B(-8.0%) |
| Sept 2003 | - | $29.87 B(-6.1%) |
| June 2003 | - | $31.82 B(+241.0%) |
| Mar 2003 | - | $9.33 B(+18.9%) |
| Dec 2002 | $7.85 B(+10.1%) | $7.85 B(+4.4%) |
| Sept 2002 | - | $7.52 B(+1.4%) |
| June 2002 | - | $7.42 B(+7.3%) |
| Mar 2002 | - | $6.91 B(-3.1%) |
| Dec 2001 | $7.13 B(+30.8%) | $7.13 B(+3.8%) |
| Sept 2001 | - | $6.87 B(-3.8%) |
| June 2001 | - | $7.14 B(+9.5%) |
| Mar 2001 | - | $6.52 B(+19.6%) |
| Dec 2000 | $5.45 B(-1.3%) | $5.45 B(+9.7%) |
| Sept 2000 | - | $4.97 B(+2.5%) |
| June 2000 | - | $4.85 B(+89.6%) |
| Mar 2000 | - | $2.56 B(-53.7%) |
| Dec 1999 | $5.53 B(+140.3%) | $5.53 B(+134.1%) |
| Sept 1999 | - | $2.36 B(+8.4%) |
| June 1999 | - | $2.18 B(-2.2%) |
| Mar 1999 | - | $2.23 B(-3.1%) |
| Dec 1998 | $2.30 B(+11.4%) | $2.30 B(+1.2%) |
| Sept 1998 | - | $2.27 B(+10.1%) |
| June 1998 | - | $2.06 B(-1.0%) |
| Mar 1998 | - | $2.08 B(+1.0%) |
| Dec 1997 | $2.06 B(+2.0%) | $2.06 B(-2.6%) |
| Sept 1997 | - | $2.12 B(+1.1%) |
| June 1997 | - | $2.10 B(+0.7%) |
| Mar 1997 | - | $2.08 B(+2.9%) |
| Dec 1996 | $2.02 B(+1.7%) | $2.02 B(+12.5%) |
| Sept 1996 | - | $1.80 B(+3.5%) |
| June 1996 | - | $1.74 B(-1.0%) |
| Mar 1996 | - | $1.76 B(-11.7%) |
| Dec 1995 | $1.99 B(+4.1%) | $1.99 B(+17.4%) |
| Sept 1995 | - | $1.69 B(-13.9%) |
| June 1995 | - | $1.97 B(-1.6%) |
| Mar 1995 | - | $2.00 B(+4.7%) |
| Dec 1994 | $1.91 B(-3.7%) | $1.91 B(-7.8%) |
| Sept 1994 | - | $2.07 B(+2.1%) |
| June 1994 | - | $2.03 B(+0.7%) |
| Mar 1994 | - | $2.02 B(+1.7%) |
| Dec 1993 | $1.98 B(+22.4%) | $1.98 B(+5.8%) |
| Sept 1993 | - | $1.87 B(+11.5%) |
| June 1993 | - | $1.68 B(+3.7%) |
| Mar 1993 | - | $1.62 B(+0.1%) |
| Dec 1992 | $1.62 B(+40.4%) | $1.62 B(+15.5%) |
| Sept 1992 | - | $1.40 B(+5.4%) |
| June 1992 | - | $1.33 B(+0.5%) |
| Mar 1992 | - | $1.32 B(+14.8%) |
| Dec 1991 | $1.15 B(+41.6%) | $1.15 B(+70.1%) |
| Sept 1991 | - | $678.20 M(-3.7%) |
| June 1991 | - | $704.30 M(-9.6%) |
| Mar 1991 | - | $779.40 M(-4.3%) |
| Dec 1990 | $814.40 M(-4.6%) | $814.40 M(+0.4%) |
| Sept 1990 | - | $811.50 M(-0.5%) |
| June 1990 | - | $815.70 M(-2.5%) |
| Mar 1990 | - | $837.00 M(-1.9%) |
| Dec 1989 | $853.30 M(-14.0%) | $853.30 M(-14.0%) |
| Dec 1988 | $992.20 M(-8.4%) | $992.20 M(-8.4%) |
| Dec 1987 | $1.08 B(+87.5%) | $1.08 B(+87.5%) |
| Dec 1986 | $577.80 M(+0.3%) | $577.80 M(+0.3%) |
| Dec 1985 | $575.90 M(+20.2%) | $575.90 M(+20.2%) |
| Dec 1984 | $479.00 M | $479.00 M |
FAQ
- What is Pfizer annual total long term liabilities?
- What is the all time high annual total long term liabilities for Pfizer?
- What is Pfizer annual total long term liabilities year-on-year change?
- What is Pfizer quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Pfizer?
- What is Pfizer quarterly long term liabilities year-on-year change?
What is Pfizer annual total long term liabilities?
The current annual total long term liabilities of PFE is $89.42 B
What is the all time high annual total long term liabilities for Pfizer?
Pfizer all-time high annual total long term liabilities is $89.42 B
What is Pfizer annual total long term liabilities year-on-year change?
Over the past year, PFE annual total long term liabilities has changed by +$30.27 B (+51.17%)
What is Pfizer quarterly total long term liabilities?
The current quarterly long term liabilities of PFE is $83.71 B
What is the all time high quarterly long term liabilities for Pfizer?
Pfizer all-time high quarterly total long term liabilities is $89.42 B
What is Pfizer quarterly long term liabilities year-on-year change?
Over the past year, PFE quarterly total long term liabilities has changed by -$2.97 B (-3.43%)